Development of a Predictive Model of Occult Cancer After a Venous Thromboembolism Event Using Machine Learning: The CLOVER Study.
Source check: Source checked. Not independent scientific confirmation.
Finding: CLOVER prospective VTE registry nested case-control (815 participants, 56 occult cancers) compares boosted-tree models; temporal split uses later cases as test. CatBoost gives the reported best performance. Testing: Small cancer-event count and temporal internal test; this is risk prediction, not validated population screening.. Source affiliation was not stated in the reviewed case checks and was unavailable in the local bibliographic cache.
Technology: CLOVER prospective VTE registry nested case-control (815 participants, 56 occult cancers) compares boosted-tree models; temporal split uses later cases as test. CatBoost gives the reported best performance.
Publication: Peer-reviewed paper · Test context: prospective or independent check. Catalog categories, not an evidence grade.
- AI contribution
- CLOVER prospective VTE registry nested case-control (815 participants, 56 occult cancers) compares boosted-tree models; temporal split uses later cases as test. CatBoost gives the reported best performance.
- Test and result
- Small cancer-event count and temporal internal test; this is risk prediction, not validated population screening.
- Limitation / still unknown
- CLOVER prospective VTE registry nested case-control (815 participants, 56 occult cancers) compares boosted-tree models; temporal split uses later cases as test. CatBoost gives the reported best performance.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.3390/medicina61010018 · https://www.mdpi.com/1648-9144/61/1/18
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 4/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.